Kotler Kevin
SEC-identified person · CIK 1601692 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Heron Therapeutics, INC. /DE/ appa | Director | filed 2023 - 2023 |
| Biodelivery Sciences International INC BDSI | Director | filed 2018 - 2022 |
| QLT INC/BC QLTI | Director | filed 2016 - 2020 |
| Flamel Technologies SA FLML | Director | filed 2017 - 2019 |
| Aratana Therapeutics, INC. PETX | Officer | filed 2017 - 2019 |
| Corium International, Inc. CORI | Officer | filed 2017 - 2018 |
| Societal Cdmo, Inc. SCTL | Officer | filed 2014 - 2018 |
| Mirati Therapeutics, Inc. mrtx | Officer | filed 2017 - 2017 |
| Progenics Pharmaceuticals INC PGNX | Officer | filed 2014 - 2017 |
| Aegerion Pharmaceuticals, Inc. AEGR | Officer | filed 2015 - 2016 |
| Strata Skin Sciences, Inc. SSKN | Officer | filed 2014 - 2016 |
| Dextera Surgical INC DXTR | Officer | filed 2015 - 2015 |
| Travere Therapeutics, Inc. TVTX | Officer | filed 2015 - 2015 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.